No, Medicaid does not pay for medical marijuana. Because cannabis remains a federally controlled substance without FDA approval, federal law prohibits Medicaid from reimbursing the cost of marijuana products in any state, even those with legal medical cannabis programs. This is a firm legal barrier, not a state-by-state policy choice.
Why Federal Law Blocks Coverage
Medicaid is jointly funded by the federal government and individual states, and federal rules set the floor for what the program can and cannot cover. The Medicaid Act limits drug reimbursement to FDA-approved medications. Cannabis has no FDA approval as a whole-plant medicine, which means it falls outside the scope of what any Medicaid program is legally allowed to pay for.
This restriction applies regardless of what your state’s marijuana laws say. A state can legalize medical cannabis, set up a dispensary system, and even encourage doctors to recommend it, but the moment Medicaid dollars enter the picture, federal law takes priority. Insurers that chose to cover cannabis could actually face legal consequences under the current federal framework.
Courts Have Upheld the Restriction
Patients and dispensaries have tried to challenge this barrier in court, without success. In a notable New Mexico case, a licensed dispensary and several Medicaid and private insurance users sued major insurers, arguing that state behavioral health laws required coverage for cannabis used to treat behavioral health conditions. The court disagreed. It ruled that the state’s benchmark insurance plan does not explicitly cover cannabis and excludes reimbursement for substances lacking FDA approval. The ruling specifically referenced the Medicaid Act’s restriction to FDA-approved drugs as a basis for denying coverage.
The plaintiffs also argued that a New Mexico law prohibiting cost-sharing for behavioral health services should apply. The court rejected this too, reasoning that because insurers aren’t required to cover medical cannabis in the first place, cost-sharing protections don’t kick in. Even proposed federal rule changes around marijuana scheduling, the court noted, have not actually altered the legal landscape enough to change this outcome.
What About Doctor Visits?
Here’s where it gets slightly more nuanced. While Medicaid won’t pay for the cannabis itself, some states do allow Medicaid to cover the doctor’s visit where you get evaluated and certified for a medical marijuana card. New York is the clearest example. The state’s Office of Cannabis Management has explicitly stated that practitioner office visits related to patient evaluation and certification for medical cannabis are Medicaid-reimbursable services.
In New York, Medicaid-participating providers are actually prohibited from charging you separately for the certification. If you see an in-network Medicaid provider, your evaluation visit is covered like any other office visit. The key detail: this only applies to providers who participate in Medicaid. If you go to an out-of-network or non-Medicaid provider for your evaluation, they can still charge you a fee. So verifying your provider’s Medicaid participation before booking is worth the phone call.
Not every state follows New York’s approach. Many states treat medical marijuana certification visits as outside the scope of Medicaid entirely, and policies vary widely. If you’re on Medicaid and considering a medical cannabis evaluation, calling your state’s Medicaid office or your provider directly is the most reliable way to find out whether the visit itself will be covered where you live.
Costs You Should Expect to Pay Out of Pocket
For most Medicaid recipients who use medical marijuana, the full cost chain comes out of pocket. That typically includes three expenses: the doctor’s evaluation (unless your state covers it like New York does), the state registration card, and the cannabis products themselves.
Evaluation fees from private cannabis clinics generally range from $100 to $300, though prices vary by state and provider. State card fees are separate and also not covered by insurance. Georgia, for example, charges $30 for a low THC oil registry card and explicitly notes that insurance does not cover it. Most states charge somewhere between $25 and $200 for their cards, with some offering reduced fees for patients on public assistance programs like Medicaid or SNAP.
The cannabis products are the largest ongoing expense. Monthly costs depend heavily on what you use, how often, and dispensary pricing in your state, but $100 to $300 per month is a common range. Some state programs and individual dispensaries offer discount programs or sliding-scale pricing for low-income patients, so it’s worth asking at your local dispensary.
Could This Change?
The federal barrier to Medicaid coverage hinges on two things: cannabis’s legal classification and its lack of FDA approval. Rescheduling cannabis from Schedule I to Schedule III, which has been proposed, would ease some federal restrictions but would not automatically make cannabis eligible for Medicaid reimbursement. FDA approval of whole-plant cannabis as a prescription medication would be the more significant threshold. Until that happens, the legal framework that courts have consistently upheld remains in place, and Medicaid programs nationwide are blocked from covering medical marijuana products.